Management of difficult infantile haemangiomas

Archives of Disease in Childhood

Volumn 97, Issue 3, 2012, Pages 266-271

  Maguiness, Sheilagh M ^a   Frieden, Ilona J ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECAPLERMIN; CORTICOSTEROID; IMIQUIMOD; METRONIDAZOLE; PEROXIDE; PETROLATUM; PREDNISOLONE; PREDNISONE; PROPRANOLOL; SODIUM CHLORIDE; STEROID; TIMOLOL MALEATE; TRIAMCINOLONE; VINCRISTINE;

ADRENAL SUPPRESSION; BLEEDING; CAPILLARY HEMANGIOMA; CLINICAL FEATURE; CLINICAL RESEARCH; CUSHINGOID SYNDROME; DRUG MEGADOSE; FUNCTIONAL DISEASE; GASTROINTESTINAL SYMPTOM; GROWTH DISORDER; HUMAN; HYPERTENSION; INFECTION; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN ATROPHY; SKIN ULCER; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADRENERGIC BETA-ANTAGONISTS; ANTINEOPLASTIC AGENTS; GLUCOCORTICOIDS; HEMANGIOMA; HUMANS; INFANT; SKIN NEOPLASMS; SKIN ULCER;

EID: 84857237824     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-300851     Document Type: Review

References (69)

1. Leonardi-Bee J, Batta K, O'Brien C, et al. Interventions for infantile haemangiomas (strawberry birthmarks) of the skin. Cochrane Database Syst Rev 2011;5:CD006545.
2. Haggstrom AN, Drolet BA, Baselga E, et al; Hemangioma Investigator Group. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007;150:291-4. (Pubitemid 46328964)
3. Frieden IJ, Rogers M, Garzon MC. Conditions masquerading as infantile haemangioma: Part 2. Australas J Dermatol 2009;50:153-68; quiz 169-70.
4. Chang LC, Haggstrom AN, Drolet BA, et al; Hemangioma Investigator Group. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008;122:360-7.
5. Chamlin SL, Haggstrom AN, Drolet BA, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr 2007;151:684-9, 689.e1.
6. Hermans DJ, Boezeman JB, Van de Kerkhof PC, et al. Differences between ulcerated and non-ulcerated hemangiomas, a retrospective study of 465 cases. Eur J Dermatol 2009;19:152-6.
7. Maguiness SM, Hoffman WY, McCalmont TH, et al. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol 2010;146:1235-9.
8. Sugarman JL, Mauro TM, Frieden IJ. Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor. Arch Dermatol 2002;138:314-16. (Pubitemid 34226327)
9. David LR, Malek MM, Argenta LC. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg 2003;56:317-27. (Pubitemid 36927263)
10. Michel JL, Patural H. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy]. Arch Pediatr 2009;16:1565-8.
11. Haggstrom AN, Lammer EJ, Schneider RA, et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006;117:698-703. (Pubitemid 46063211)
12. Jackson IT. Nasal tip hemangioma. Plast Reconstr Surg 2002;110:1814.
13. Reeh MJ. The Cyrano nose: a clinical review of hemangioma of the nasal tip. Plast Reconstr Surg 1979;64:394-5.
14. Mandrekas AD, Zambacos GJ, Hapsas DA. Pediatric nasal reconstruction for nasal tip hemangioma. Plast Reconstr Surg 2010;125:1571-2; author reply 1573.
15. Mulliken JB, Rogers GF, Marler JJ. Circular excision of hemangioma and purse-string closure: the smallest possible scar. Plast Reconstr Surg 2002;109:1544-54; discussion 1555.
16. Bilyk JR, Adamis AP, Mulliken JB. Treatment options for periorbital hemangioma of infancy. Int Ophthalmol Clin 1992;32:95-109.
17. Achauer BM, Celikoz B, VanderKam VM. Intralesional bare fi ber laser treatment of hemangioma of infancy. Plast Reconstr Surg 1998;101:1212-17. (Pubitemid 28152693)
18. Aldave AJ, Shields CL, Shields JA. Surgical excision of selected amblyogenic periorbital capillary hemangiomas. Ophthalmic Surg Lasers 1999;30:754-7. (Pubitemid 29534143)
19. Cruz OA, Zarnegar SR, Myers SE. Treatment of periocular capillary hemangioma with topical clobetasol propionate. Ophthalmology 1995;102:2012-15. (Pubitemid 26004461)
20. Tronina SA, Bobrova NF, Khrinenko VP. Combined surgical method of orbital and periorbital hemangioma treatment in infants. Orbit 2008;27:249-57.
21. Kulkarni ML, Kumar CS, George VG, et al. Oral steroids in the treatment of periorbital hemangioma. Indian Pediatr 1993;30:379-82. (Pubitemid 23122467)
22. Jalil A, Maino A, Bhojwani R, et al. Clinical review of periorbital capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus 2011;48:218-25.
23. Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010;126:e418-26.
24. Metry D, Heyer G, Hess C, et al; PHACE Syndrome Research Conference. Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics 2009;124:1447-56.
25. Metry DW, Haggstrom AN, Drolet BA, et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical fi ndings, and complications. Am J Med Genet A 2006;140:975-86.
26. Hess CP, Fullerton HJ, Metry DW, et al. Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 2010;31:1980-6.
27. Stockman A, Boralevi F, Taïeb A, et al. SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatology (Basel) 2007;214:40-5. (Pubitemid 46032999)
28. Girard C, Bigorre M, Guillot B, et al. PELVIS Syndrome. Arch Dermatol 2006;142:884-8. (Pubitemid 44079789)
29. Iacobas I, Burrows PE, Frieden IJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr 2010;157:795-801.e1-7.
30. Drolet BA, Chamlin SL, Garzon MC, et al. Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin. J Pediatr 2010;157:789-94.
31. Horii KA, Drolet BA, Baselga E, et al. Hemangioma Investigator Group. Risk of hepatic hemangiomas in infants with large hemangiomas. Arch Dermatol 2010;146:201-3.
32. Christison-Lagay ER, Burrows PE, Alomari A, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 2007;42:62-7; discussion 67-8.
33. Bessho K, Etani Y, Ichimori H, et al. Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr 2010;169:215-21.
34. Cho YH, Taplin C, Mansour A, et al. Case report: consumptive hypothyroidism consequent to multiple infantile hepatic haemangiomas. Curr Opin Pediatr 2008;20:213-15. (Pubitemid 351365713)
35. Cuccaro P, Rapacciuolo A, Vitiello R, et al. Propranolol for severe hemangioma of infancy. J Cardiovasc Med (Hagerstown) 2011;12:5.
36. Ferraz AA, Sette MJ, Maia M, et al. Liver transplant for the treatment of giant hepatic hemangioma. Liver Transpl 2004;10:1436-7. (Pubitemid 39530062)
37. Zenzen W, Perez-Atayde AR, Elisofon SA, et al. Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol 2009;39:1118-23.
38. Al-Sebeih K, Manoukian J. Systemic steroids for the management of obstructive subglottic hemangioma. J Otolaryngol 2000;29:361-6.
39. Rosbe KW, Suh KY, Meyer AK, et al. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 2010;136:658-65.
40. Blanchet C, Nicollas R, Bigorre M, et al. Management of infantile subglottic hemangioma: acebutolol or propranolol? Int J Pediatr Otorhinolaryngol 2010;74:959-61.
41. Holmes WJ, Mishra A, Gorst C, et al. Propranolol as fi rst-line treatment for infantile hemangiomas. Plast Reconstr Surg 2010;125:420-1.
42. Ni N, Langer P, Wagner R, et al. Topical timolol for periocular hemangioma: reportof further study. Arch Ophthalmol 2011;129:377-9.
43. Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010;146:564-5.
44. Senchak AJ, Dann M, Cable B, et al. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases. Ear Nose Throat J 2010;89:E21-5.
45. Hazen PG, Carney JF, Engstrom CW, et al. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream. Pediatr Dermatol 2005;22:254-6. (Pubitemid 40741266)
46. Martinez MI, Sanchez-Carpintero I, North PE, et al. Infantile hemangioma: clinical resolution with 5% imiquimod cream. Arch Dermatol 2002;138:881-4; discussion 884.
47. McCuaig CC, Dubois J, Powell J, et al. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol 2009;26:203-12.
48. Brown BZ, Huffaker G. Local injection of steroids for juvenile hemangiomas which disturb the visual axis. Ophthalmic Surg 1982;13:630-3. (Pubitemid 13230515)
49. Egbert JE, Schwartz GS, Walsh AW. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J Ophthalmol 1996;121:638-42. (Pubitemid 26183743)
50. Zaher H, Rasheed H, Hegazy RA, et al. Oral propranolol: an effective, safe treatment for infantile hemangiomas. Eur J Dermatol 2011;21:558-63.
51. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. (Pubitemid 351831393)
52. Zvulunov A, McCuaig C, Frieden IJ, et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr Dermatol 2011;28:94-8.
53. Fabian ID, Ben-Zion I, Samuel C, et al. Reduction in astigmatism using propranolol as fi rst-line therapy for periocular capillary hemangioma. Am J Ophthalmol 2011;151:53-8.
54. Fay A, Nguyen J, Jakobiec FA, et al. Propranolol for isolated orbital infantile hemangioma. Arch Ophthalmol 2010;128:256-8.
55. Sarialioglu F, Erbay A, Demir S. Response of infantile hepatic hemangioma to propranolol resistant to high-dose methylprednisolone and interferon-a therapy. Pediatr Blood Cancer 2010;55:1433-4.
56. Sciveres M, Marrone G, Pipitone S, et al. Successful fi rst-line treatment with propranolol of multifocal infantile hepatic hemangioma with high-fl ow cardiac overload. J Pediatr Gastroenterol Nutr 2011;53:693-5.
57. Taban M, Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology 2010;117:195-195.e4.
58. Truong MT, Chang KW, Berk DR, et al. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr 2010;156:335-8.
59. Abbott J, Parulekar M, Shahidullah H, et al. Diarrhea associated with propranolol treatment for hemangioma of infancy (HOI). Pediatr Dermatol 2010;27:558.
60. Holland KE, Frieden IJ, Frommelt PC, et al. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010;146:775-8.
61. Pavlakovic H, Kietz S, Lauerer P, et al. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics 2010;126:e1589-93.
62. Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 2011;128:e259-66.
63. Cohen SR, Wang CI. Steroid treatment of hemangioma of the head and neck in children. Ann Otol Rhinol Laryngol 1972;81:584-90.
64. Pandey A, Gangopadhyay AN, Gopal SC, et al. Twenty years' experience of steroids in infantile hemangioma-a developing country's perspective. J Pediatr Surg 2009;44:688-94.
65. Bennett ML, Fleischer AB Jr, Chamlin SL, et al. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001;137:1208-13. (Pubitemid 32847844)
66. Enjolras O, Brevière GM, Roger G, et al. [Vincristine treatment for function- and life-threatening infantile hemangioma]. Arch Pediatr 2004;11:99-107.
67. Blei F, Orlow SJ, Geronemus RG. Interferon alfa-2a therapy for extensive perianal and lower extremity hemangioma. J Am Acad Dermatol 1993;29:98-9. (Pubitemid 23197204)
68. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132:527-30. (Pubitemid 28180264)
69. Michaud AP, Bauman NM, Burke DK, et al. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004;114:1231-6. (Pubitemid 38954577)